Cetaphil Targets Restoraderm To Consumers With Eczema, Atopic Dermatitis
This article was originally published in The Rose Sheet
Executive Summary
Galderma's Cetaphil skin-care brand looks to reach new demographics with its recent introduction of a "disease-specific" product line
You may also be interested in...
L'Oreal Branches Out, Targets One Billion New Customers In 10 Years
Focusing on "accessible innovation," L'Oreal SA plans to increase its share in emerging markets and add one billion to its consumer base, according to CEO Jean-Paul Agon
Market In Brief
Galderma: New Cetaphil UVA/UVB Defense SPF 50 "is fragrance-free, non-irritating and non-comedogenic, so it won't clog pores, making it a suitable choice for those with acne, rosacea or melasma and other skin-related conditions where a hydrating formula with SPF protection is recommended," cosmeceutical firm says. Product, which flaunts the Skin Cancer Foundation Seal of Recommendation, is formulated with an "optimum blend" of four UV filters and micronized titanium dioxide for broad-spectrum protection. It retails for $13.99 for 1.7 oz. at major retail, grocery and drug stores nationwide, according to Galderma, which was launched in 1981 as a joint venture between Nestle and L'Oreal
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program